Aspen Aerogels, Inc. (NYSE:ASPN) Receives $28.70 Consensus PT from Brokerages

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) have earned a consensus recommendation of “Buy” from the nine research firms that are covering the company, MarketBeat reports. Eight research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $30.00.

A number of brokerages recently weighed in on ASPN. Piper Sandler decreased their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. HC Wainwright reiterated a “buy” rating and issued a $30.00 target price on shares of Aspen Aerogels in a research note on Wednesday, October 16th. StockNews.com raised Aspen Aerogels to a “sell” rating in a research report on Wednesday, November 13th. Barclays lowered their price objective on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research report on Tuesday, November 12th. Finally, Roth Mkm reduced their target price on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research report on Friday, November 8th.

Insider Buying and Selling at Aspen Aerogels

In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction dated Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares in the company, valued at approximately $14,523,709.20. This trade represents a 11.58 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 4.30% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. Bank of New York Mellon Corp raised its holdings in Aspen Aerogels by 26.2% during the second quarter. Bank of New York Mellon Corp now owns 226,666 shares of the construction company’s stock valued at $5,406,000 after buying an additional 46,988 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Aspen Aerogels by 10.3% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,310 shares of the construction company’s stock valued at $341,000 after acquiring an additional 1,339 shares in the last quarter. nVerses Capital LLC acquired a new stake in Aspen Aerogels in the 2nd quarter worth approximately $95,000. Rhumbline Advisers lifted its holdings in Aspen Aerogels by 13.7% in the 2nd quarter. Rhumbline Advisers now owns 93,226 shares of the construction company’s stock worth $2,223,000 after purchasing an additional 11,205 shares during the last quarter. Finally, Victory Capital Management Inc. acquired a new position in Aspen Aerogels during the second quarter valued at approximately $230,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Stock Up 0.6 %

Shares of ASPN opened at $12.47 on Thursday. The firm has a market cap of $1.02 billion, a PE ratio of 1,248.25 and a beta of 2.11. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The company’s fifty day moving average is $15.24 and its two-hundred day moving average is $21.70. Aspen Aerogels has a fifty-two week low of $10.75 and a fifty-two week high of $33.15.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.